Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.

Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.

The protein PNA5 could possibly prevent cognitive decline in people who have Parkinson's disease and related disorders, researchers report.

Surgical patients are opting out of opioids due to concerns about side effects and addiction. Combining methods to manage pain can take these fears into account without compromising on care.

A new study shows how psilocybin-assisted therapy could impact more than 5 million people in the US pending approval from the FDA.

The needle-free device could be used to deliver insulin, antibodies, RNA, or other large molecules.

The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.

Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.

The sellers of these online products acknowledge that many of their drugs are for ‘research purposes only’ or ‘not for human consumption.’

Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in physiology or medicine for their discovery of microRNAs, molecules that turn genes on and off – and cause disease when they go awry.